Re: Resistance to Docetaxel in Prostate Cancer is Associated with Androgen Receptor Activation and Loss of KDM5D Expression

2017 ◽  
Vol 197 (1) ◽  
pp. 154-155 ◽  
Author(s):  
Anthony Atala
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Receptor Activation ◽  
Androgen Receptor Activation

Androgen receptor activation results in metabolite signatures of an aggressive prostate cancer phenotype: an NMR-based metabonomics study

Metabolomics ◽  
2012 ◽  
Vol 8 (6) ◽  
pp. 1026-1036 ◽  
Author(s):  
Neil MacKinnon ◽  
Amjad P. Khan ◽  
Arul M. Chinnaiyan ◽  
Thekkelnaycke M. Rajendiran ◽  
Ayyalusamy Ramamoorthy
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Receptor Activation ◽  
Aggressive Prostate Cancer ◽  
Cancer Phenotype ◽  
Androgen Receptor Activation

Requirement for NF-κB in interleukin-4-induced androgen receptor activation in prostate cancer cells

The Prostate ◽  
2005 ◽  
Vol 64 (2) ◽  
pp. 160-167 ◽  
Author(s):  
Soo Ok Lee ◽  
Wei Lou ◽  
Nagalakshmi Nadiminty ◽  
Xin Lin ◽  
Allen C. Gao
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cancer Cells ◽  
Receptor Activation ◽  
Interleukin 4 ◽  
Prostate Cancer Cells ◽  
Androgen Receptor Activation
Sign in / Sign up

Export Citation Format

Share Document